BofA raised the firm’s price target on MetLife (MET) to $104 from $100 and keeps a Buy rating on the shares. The firm is updating its price targets for U.S. Insurance companies under its coverage, the analyst tells investors. Q3 turned out to be a “relatively calm” season without any hurricanes making landfall in the U.S. and, while 1H saw elevated levels of macro uncertainties, this did not translate to material adverse impact on earnings, the firm says.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MET:
- MetLife price target raised to $98 from $93 at Barclays
- MetLife price target raised to $97 from $94 at Morgan Stanley
- MetLife Announces Preliminary Q3 2025 Investment Income
- Intel downgraded, Tesla upgraded: Wall Street’s top analyst calls
- MetLife downgraded to Neutral from Overweight at Piper Sandler